Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000198493 | SCV000250417 | likely pathogenic | not provided | 2024-08-12 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); Stop codon loss and change to a stop codon, leading to protein extension and the addition of 100 amino acids at the C-terminus in a gene for which protein extension is a known mechanism of disease; Also known as p.(Ter2648SerextTer101); This variant is associated with the following publications: (PMID: 28428218, 23873601) |
Baylor Genetics | RCV003333048 | SCV004041354 | pathogenic | Heterotopia, periventricular, X-linked dominant | 2023-02-09 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003765249 | SCV004604770 | pathogenic | Heterotopia, periventricular, X-linked dominant; Melnick-Needles syndrome; Oto-palato-digital syndrome, type II; Frontometaphyseal dysplasia | 2024-02-07 | criteria provided, single submitter | clinical testing | This sequence change disrupts the translational stop signal of the FLNA mRNA. It is expected to extend the length of the FLNA protein by 100 additional amino acid residues. This variant is not present in population databases (gnomAD no frequency). This protein extension has been observed in individual(s) with bilateral periventricular heterotopia, congenital short bowel, and additional FLNA-related conditions (PMID: 23873601, 28428218). It has also been observed to segregate with disease in related individuals. This variant is also known as c.7941_7942delCT (p.2648Serext*100). ClinVar contains an entry for this variant (Variation ID: 213498). Studies have shown that this protein extension alters FLNA gene expression (PMID: 23873601, 28428218). For these reasons, this variant has been classified as Pathogenic. |